- Steady as she goes, milestones recognised and passed
- Cash position, very strong and spending frugal and highly targeted
- no need to approach the market, if institutions want script, then buy on market
- Stage 2 ....results very promising
- stage 3 enrolling...............the rubber hits the road with Specificity, Sensitivity figures
- Gen 2 arising
- Focus on the FDA around the skeleton of the final submission
- Market 2025..........................and then......................
Steady as she goes, milestones recognised and passedCash...
Add EMV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.86 |
Change
-0.055(2.87%) |
Mkt cap ! $158.8M | |||
| Open | High | Low | Value | Volume |
| $1.92 | $1.92 | $1.85 | $157.3K | 84.36K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 200 | $1.85 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.87 | 16 | 1 |
View Market Depth
| Last trade - 16.10pm 29/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.86 |
Change
-0.055 ( 4.94 %) |
||||
| Open | High | Low | Volume | ||
| $1.90 | $1.90 | $1.85 | 19925 | ||
| Last updated 15.59pm 29/05/2024 ? | |||||
| EMV (ASX) Chart |